Biomarkers
View abstract on PubMed
Summary
This summary is machine-generated.Combining electroencephalography (EEG) and NIH Toolbox-Cognition Battery (NIHTB-CB) data significantly improves the accuracy of detecting mild cognitive impairment (MCI). This combined approach offers a more sensitive method for early Alzheimer
Area Of Science
- Neuroscience
- Cognitive Science
- Biomedical Engineering
Background
- Early identification of individuals at risk for Alzheimer's disease and related dementias is crucial for timely interventions and enhanced quality of life.
- This study aimed to enhance the classification accuracy of normal cognition (NC) and mild cognitive impairment (MCI) by integrating electroencephalography (EEG) data with the NIH Toolbox-Cognition Battery (NIHTB-CB).
Purpose Of The Study
- To evaluate the diagnostic performance of EEG alone, NIHTB-CB alone, and a combined EEG + NIHTB-CB approach for differentiating between normal cognition and mild cognitive impairment.
- To determine if incorporating cognitive assessment scores can improve the discriminative power of EEG-based analyses for MCI detection.
Main Methods
- Utilized data from 71 participants (40 NC, 31 MCI) with both 64-channel resting-state EEG and NIHTB-CB assessments.
- NIHTB-CB included tests of crystallized and fluid abilities, processing speed, attention, working memory, and visual memory.
- Compared classification accuracy using k-fold cross-validation (k=3, 5, 10) for EEG alone, NIHTB-CB alone, and the combined approach, averaging results over 50 random test set selections.
Main Results
- The combined EEG + NIHTB-CB model achieved the highest 10-fold test accuracy at 78.82%, outperforming EEG alone (75.49%) and NIHTB-CB alone (65.89%).
- The 10-fold cross-validation accuracy for the combined model, utilizing all samples for feature selection, reached 93.1%.
- A similar trend favoring the combined approach was observed for k=3 and k=5 cross-validation.
Conclusions
- The integration of NIHTB-CB cognitive scores with EEG data significantly enhances the accuracy of mild cognitive impairment detection compared to either method alone.
- The combined EEG + NIHTB-CB model demonstrates superior sensitivity for MCI detection, highlighting the synergistic value of multimodal data.
- Increased sample size contributes to more reliable feature selection and classification in cognitive impairment studies.
Related Concept Videos
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

